4D Molecular Therapeutics, Inc. FDMT
11.95 USD +0.58 (+5.10%)
At closeNov 3, 2026, 4:00 PM EST
11.95 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
11.46 Day range 12.08
6.96 52-week range 16.93
- YTD
- +59.33%
- 1 year
- +6.51%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 85.21M | 37.00K | 20.72M | 3.13M | 18.04M | |
| 85.21M | 37.00K | 20.72M | 3.13M | 18.04M | |
| -159.55M | -187.84M | -112.87M | -110.03M | -71.33M | |
| -140.11M | -160.87M | -100.84M | -107.49M | -71.32M | |
| -2.42 | -2.98 | -2.58 | -3.32 | -2.57 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 60.24M | 149.34M | 249.11M | 52.35M | 153.00M | |
| 566.71M | 560.38M | 339.89M | 261.85M | 353.49M | |
| 61.05M | 49.78M | 32.06M | 30.51M | 34.38M | |
| 21.41M | 24.61M | 14.67M | 16.12M | 16.45M | |
| 505.66M | 510.61M | 307.83M | 231.34M | 319.11M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -109.08M | -134.59M | -75.79M | -86.69M | -69.13M | |
| -92.97M | -302.44M | 115.72M | -17.05M | -172.68M | |
| 112.96M | 337.25M | 156.83M | 3.08M | 118.09M | |
| -536.00K | -3.79M | -2.77M | -11.54M | -9.11M | |
| -89.09M | -99.77M | 196.76M | -100.65M | -123.72M |